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Introduction
Pulmonary eosinophilic pneumonias 
include a heterogeneous group of disorders 
characterized by the presence of eosinophils 
in the lungs as detected by bronchoalveolar 
lavage or tissue biopsy, with or without 
blood eosinophilia (Tables 1 and 2).
1
 
Although the inflammatory infiltrate in the 
lungs is composed of macrophages, 
lymphocytes, neutrophils, and eosinophils, 
eosinophilia is an important marker for the 
diagnosis.  
Idiopathic acute eosinophilic pneumonia 
(IAEP) is a rapidly progressive disease of 
healthy adults, described in 1989.
2,3
 It is 
reported worldwide
4
 and thought to be an 
allergic response to an environmental 
stimulus, sometimes associated with early 
cigarette smoking.
5
 IAEP is a diagnosis of 
exclusion and should be considered in the 
differential of a sudden unexplained hypoxia 
and extensive pulmonary infiltrates.  
 
Case Report  
A 55-year-old Caucasian male presented 
with a seven-day history of losing ten 
pounds and night sweats. He had 
progressive shortness of air over the 
previous day and one-half. He was 
hypoxemic requiring 5-6 liters of oxygen by 
nasal canula and had bilateral infiltrates on 
chest x-ray (Figure 1) and computer 
tomography of the chest (Figure 2). Initial 
Table 1. Classification of pulmonary 
eosinophilia based on clinical-radiological 
presentation.
1
 
1) Simple pulmonary eosinophilia 
2) Chronic eosinophilic pneumonia 
3) Acute eosinophilic pneumonia 
4) Allergic bronchopulmonary aspergillosis 
5) Pulmonary eosinophilia associated with 
a systemic disease 
a) Churg-Strauss syndrome 
b) Hypereosinophilic syndrome 
 
Table 2. Classification based on etiology of 
the forms of pulmonary eosinophilia.
1
 
1) Primary or idiopathic 
2) Secondary 
a) Known causes: drugs, parasites, toxic 
products/irradiation, fungal and 
mycobacterial infection 
b) Diffuse lung diseases: cryptogenic 
organizing pneumonia; hyper-
sensitivity pneumonia; idiopathic 
pulmonary fibrosis; Langerhans cell 
histiocytosis; sarcoidosis 
c) Malignant diseases: leukemia, lym-
phoma, lung cancer, adenocarcinoma 
involving multiple organs, squamous 
carcinoma involving multiple organs 
d) Connective tissue diseases: rheu-
matoid arthritis, Sjögren’s syndrome 
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laboratory work showed leucocytosis at 
19,800 mcL without eosinophilia and 
bandemia of 16%. He had been exposed to 
tuberculosis in the past and tested positive 
on the tuberculosis skin test, however, he 
never had symptoms nor been treated. 
Active tuberculosis was ruled out. He also 
tested negative for atypical pneumonia 
including legionella, mycoplasma, and 
chlamydia. He also was checked for human 
immunodeficiency virus, vasculitis with 
antinuclear and antineutrophil cytoplasmic 
antibodies, and fungal infection including 
histoplasma. All tests were negative. 
Sputum for gram stain and culture was 
positive for Staphylococcus aureus. Later, 
candida showed on culture which was 
thought to be commensal. The patient 
continued to be hypoxemic requiring about 
six liters of oxygen despite appropriate 
antibiotics and supportive treatment. 
 
 
Figure 1 . Chest x-ray shows diffuse airspace consolidation. 
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Figure 2.  CT of the chest shows irregular, pred inantly 
alveolar, infiltrate involving upper lobes bilaterally with 
lesser involvement of the lower lobes (not shown). 
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Bronchoalveolar lavage subsequently 
showed eosinophilia of 86%. A diagnosis of 
idiopathic acute eosinophilic pneumonia was 
made. The patient was started on IV steroid 
therapy as other causes for eosinophilia had 
been ruled out. The patient responded 
dramatically to steroids and was taken off 
oxygen in two days. He was sent home on 
tapering doses of steroids and antibiotics for 
methicillin resistant Staphylococcus aureus. 
 
Discussion 
Simple pulmonary eosinophilia is 
characterized by migratory pulmonary 
infiltrates in patients with eosinophilia and 
few or no pulmonary symptoms.
6,7
 
Pulmonary infiltrates are peripheral with a 
pleural base. Drugs and ascariasis are the 
most common causes. In one-third of cases, 
simple pulmonary eosinophilia is idiopathic. 
The prognosis is excellent. Corticosteroids 
are rarely necessary. Spon-taneous 
resolution occurs within 30 days. 
Chronic eosinophilic pneumonia (CEP) 
is a severe disease of insidious onset with 
nonspecific respiratory and systemic 
symptoms.
8,9
 Typically, CEP is idiopathic. 
The radiological profile is suggestive of 
peripheral consolidation that responds to 
corticosteroids, although it has a high 
recurrence rate. It can be secondary to drugs, 
parasites, and irradiation for breast cancer, or 
be associated with rheumatoid arthritis.
10
 It 
has been described after childbirth
11,12
 and 
desensitization using immunotherapy 
(allergy shots).
12
  
The diagnosis is made on clinical 
criteria, a suggestive radiological profile, 
and the presence of peripheral eosinophilia 
or eosinophilia in the bronchoalveolar 
lavage fluid.
1
 A rapid response to 
corticosteroids facilitates confirmation of the 
diagnosis. Spontaneous resolution is rare 
(occurring in only 10% of cases). There is a 
high recurrence rate after discontinuation of 
steroids. 
Allergic bronchopulmonary asper-
gillosis (ABPA) is a complex hyper-
sensitivity reaction that occurs when airways 
become colonized by aspergillus.
13
 The 
following criteria are considered essential 
for a diagnosis of ABPA: asthma with 
central bronchiectasis or pulmonary 
infiltrates, positive skin test reactivity to 
aspergillus, total IgE levels greater than 
1,000 U/L, and IgE or IgG against 
aspergillus in the blood. Based on disease 
activity, ABPA can be classified as having 
four distinct stages: remission, exacer-
bation, corticosteroid-dependent, and 
fibrotic phase.
1
  
Chugg Straus Syndrome (CSS) or 
allergic granulomatosis and angiitis is a 
vasculitic disorder often characterized by 
sinusitis, asthma, and prominent peripheral 
blood eosinophilia.
14
 CSS needs the 
following criteria for the diagnosis with 
confirmation of at least four being 
necessary: asthma, eosinophilia (greater than 
1,500 cells/mm
3
), paranasal sinus 
involvement, transient pulmonary infiltrates, 
mononeuropathy or poly-neuropathy, and 
biopsy findings of vasculitis. The disease 
pattern has such a distinct profile that it 
sometimes allows the diagnosis to be made 
clinically.
15
 This syndrome is characterized 
by three phases: (1) allergic phase: presence 
of asthma or rhinitis, (2) eosinophilic phase: 
presence of severe persistent peripheral 
eosinophilia (greater than 1,500 cells/mm
3
) 
for more than 6 months, and (3) vasculitic 
phase: presence of systemic manifestations 
and small vessel vasculitis, represented by 
the involvement of two or more extra 
pulmonary organs.  
Hypereosinophilic syndrome (HES) is 
rare and typically results in death.
16
 HES 
presents persistent eosinophilia (greater than 
1,500 cells/mm
3
; 30-70% of total leukocyte 
count) for more than six months. Organ 
involvement mainly includes the skin, the 
heart, the nervous system, and the 
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hematological system. The cytotoxicity of 
the major basic protein and eosinophil 
cationic protein content of eosinophils 
explains various instances of organ 
involvement in HES. The diagnosis is based 
on three criteria: persistent eosinophilia for 
at least six months or death within six 
months due to the signs and symptoms 
related to eosinophilia, eosinophilia-related 
involvement of at least one organ, and 
absence of a known cause of eosinophilia, 
such as drugs, parasites, malignancy, 
vasculitis, CEP, and CSS.
17
  
Acute eosinophilic pneumonia (AEP) 
includes acute respiratory failure, fever, 
diffuse pulmonary infiltrate, and severe 
eosinophilia in the bronchoalveolar lavage 
(BAL) fluid or in lung tissue.
18,19
 Histo-
logical examination reveals eosinophil 
infiltration and edema in the alveolar spaces 
and interstitium, including the interlobular 
septa. In the lung tissues, there is a release 
of eosinophil chemotactic cytokines, 
granulocyte-macrophage col-ony-
stimulating factor (GM-CSF), IL-3, IL-5, 
and IL-1B, all of which accumulate and are 
seen in the BAL fluid without an increase in 
the blood. This explains tissue eosinophilia 
without peripheral eosinophilia.  
Pulmonary eosinophilia presents the 
greatest number of eosinophils in lung 
tissue. The granules containing toxic 
proteins explain why the tissue injury is so 
severe. Since the proteolytic potential of 
eosinophils is lower than neutrophils, the 
acute lung injury is reversible and there are 
no sequelae.
20
 AEP can be caused by drugs 
as sertraline, BCG, minocycline, injectable 
progesterone, and inhaled cocaine. It also 
can be caused by passage of parasites 
through the lung, fungi, and inhalation of 
toxic products, but is most often 
idiopathic.
18
 
 
 
 
Idiopathic acute eosinophilic pneumonia 
IAEP is a treatable cause of acute 
hypoxic respiratory failure.
21
 IAEP is a 
diagnosis of exclusion and consisting of an 
acute febrile illness of short duration 
(usually less than one week), hypoxemic 
respiratory failure, diffuse pulmonary 
opacities on chest radiograph, BAL 
eosinophilia great than 25 percent, lung 
biopsy evidence of eosinophilic infiltrates 
(acute and/or organizing diffuse alveolar 
damage with prominent eosinophilia as the 
most characteristic finding) and absence of 
known causes of eosinophilic pneumonia, 
including drugs, infections, asthma, or 
atopic disease. IAEP can occur at any age, 
even in previously healthy children, though 
most patients are between 20 and 40 years of 
age.
6,22
 Men are affected approximately 
twice as frequently as women.
2,4,18,23
  
Patients present with an acute febrile 
illness of less than three weeks duration, 
nonproductive cough and dyspnea.
23,24
 
Associated symptoms and signs include 
malaise, myalgias, night sweats, and 
pleuritic chest pain. Physical examination 
shows fever (often high) and tachypnea. 
Bibasilar inspiratory crackles and 
occasionally rhonchi on forced exhalation 
are heard upon auscultation of the chest.  
Hypoxemic respiratory insufficiency is 
identified frequently at presentation and 
often requires mechanical ventilation.
5
 
Patients generally present with an initial 
neutrophilic leukocytosis.
5,25
 In most cases, 
the eosinophil fraction becomes markedly 
elevated during the subsequent course of 
IAEP.
5,20,24
 The erythrocyte sedimentation 
rate is elevated. The IgE level has been high 
in a majority of the patients in whom it was 
measured.
18,23,26
 When pleural fluid is 
present, it may demonstrate a marked  
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eosinophilia with a high pH.
23
 Diagnosis is 
based on analysis of the BAL fluid. Unlike 
in CEP  (in which lymphocyte and 
neutrophil counts are normal), the severe 
eosinophilia in IAEP (percentage of 
eosinophils greater than 25%) is 
accompanied by about 20% lymphocytes 
and 15% neutrophils; whereas, in acute 
respiratory distress syndrome, there is a 
predominance of neutrophils. 
At the onset of IAEP, the chest 
radiograph may show only subtle reticular or 
ground glass opacities, often with Kerley B 
lines.
21
 Most often, bilateral diffuse mixed 
alveolar and reticular opacities are seen on 
plain chest radiographs.
2,3
 Small bilateral 
pleural effusions are common (in up to 70 
percent of patients).
5
 CT findings in IAEP 
include ground-glass attenuation, airspace 
consolidation, poorly defined nodules, inter-
lobular septal thickening, and pleural 
effusions. The triad of interlobular septal 
thickening, bronchovascular bundle thick-
ening, and pleural effusions are most 
suggestive of IAEP.
27
 
Lung biopsy when performed is mainly 
to rule out infection, especially by fungi 
such as aspergillus.
28
 Biopsy findings of 
acute and organizing diffuse alveolar 
damage are common. Hyaline membranes 
and interstitial widening (due to a 
combination of edema, fibroblast prolifer-
ation, and inflammatory cells characteristic 
of the organizing phase of diffuse alveolar 
damage) is seen in most cases. Marked 
numbers of interstitial and lesser numbers of 
alveolar eosinophils are found. Other 
features include type II pneumocyte 
hyperplasia (55 percent of cases), interstitial 
lymphocytes (100 percent of cases), an 
organizing intraalveolar fibrinous exudate 
(100 percent of cases), and perivascular and 
intramural inflammation without necrosis 
(33 percent of cases). Granulomas and 
alveolar hemorrhage are absent.  
Patients with IAEP can be treated with 
methylprednisolone (60-125 mg) every six 
hours.
4,29
 Corticosteroids are the mainstay of 
treatment beside treating the underlying 
cause, if identified. Improvement occurs 
rapidly (1-3 days). The dose can be reduced 
to 40-60 mg/day and tapered over the 
subsequent 2-4 weeks. Although spon-
taneous remissions occur, most cases will be 
progressive if not treated. IAEP is not 
accompanied by multiple organ failure (as 
opposed to acute respiratory distress 
syndrome) if treated, therefore, it has a good 
prognosis. After treatment, there should be 
no relapse. 
 
Conclusion 
Idiopathic acute eosinophilic pneumonia 
is a treatable cause of acute hypoxic 
respiratory failure. It is important to 
recognize and treat this rare reversible non-
infectious cause of pneumonia and 
respiratory failure, as not treating may lead 
to a chronic debilitating disease or death. 
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